Pulse Biosciences (PLSE) Change in Accured Expenses (2015 - 2025)

Pulse Biosciences' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$1.6 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 150.76% year-over-year to -$1.6 million; the TTM figure through Dec 2025 stood at -$3.4 million (down 207.41% YoY), while the FY2025 annual figure was -$3.4 million, down 207.41% from the prior year.
• Change in Accured Expenses was -$1.6 million for Q4 2025 at Pulse Biosciences, down from $427000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $3.2 million in Q4 2024 to a low of -$3.0 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $86315.8 across 5 years, with a median of $215000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses plunged 417.28% in 2023, then surged 454.47% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $636000.0 in 2021, then slumped by 146.38% to -$295000.0 in 2022, then soared by 374.58% to $810000.0 in 2023, then surged by 295.68% to $3.2 million in 2024, then slumped by 150.76% to -$1.6 million in 2025.
• The last three Change in Accured Expenses figures came in at -$1.6 million (Q4 2025), $427000.0 (Q3 2025), and $793000.0 (Q2 2025), per Business Quant data.